俄罗斯COVID-19疫苗犹豫与拒绝的决定因素
本研究利用俄罗斯全国代表性成人数据,探讨COVID-19疫苗接种犹豫与拒绝的范围及其决定因素。结果显示,在全国接种计划启动前,仅45%的俄罗斯人口对COVID-19疫苗接种持积极态度。研究分析了人口学、社会经济和健康相关因素与接种意愿的关系,并从人格特质、宗教性和信任角度探究犹豫的深层原因。
要点
- 全国接种计划启动前,仅45%的俄罗斯成年人口对COVID-19疫苗接种持积极态度。
- 截至2021年10月中旬,仅36%的人口至少接种一剂疫苗。
- 大量疫苗犹豫和拒绝对公共卫生构成威胁,并推迟社会和经济复苏。
核心结论
- 全国接种计划启动前,仅45%的俄罗斯人口对COVID-19疫苗接种持积极态度。
- 大量疫苗犹豫和拒绝对公共卫生构成重大威胁,并推迟社会和经济复苏。
- 研究结果对设计促进疫苗接种的政策措施至关重要。
研究设计与样本
- 研究使用俄罗斯全国代表性一般成年人口数据。
- 研究分析了人口学、社会经济和健康相关因素与疫苗接种意愿的关系。
- 研究通过人格特质、宗教性和信任探究疫苗犹豫的深层原因。
主要发现
- 全国接种计划启动前,仅45%的俄罗斯人口对COVID-19疫苗接种持积极态度。
- 截至2021年10月中旬,仅36%的人口至少接种一剂疫苗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination is the main tool available to handle the COVID-19 pandemic globally. Though no vaccine is proven to be 100% effective, vaccination secures against getting seriously ill and dying from the disease. Russia announced the development of its first domestic vaccine back in August 2020 and launched the nationwide immunization campaign at the beginning of 2021. Despite these achievements, as of mid-October 2021, only 36% of the population got at least one shot of the vaccine. Massive vaccination hesitancy and refusal pose a great threat to public health and postpone social and economic recovery. Using nationally representative data from the general adult population of Russia, this study explores the scope of vaccination hesitancy and refusal as well as the determinants of vaccination attitudes. The results suggest that only 45% of the Russian population demonstrated positive attitudes towards the COVID-19 vaccination prior to the launch of a nationwide vaccination program. We analyze a wide array of demographic, socio-economic, and health-related factors in relation to vaccination intentions and explore the deep-rooted causes of vaccination reluctance by looking at personality traits, religiosity, and trust. The obtained results are vital for designing policy measures to promote vaccination.
引用
- Roshchina Y, Roshchin S, Rozhkova K, et al. Determinants of COVID-19 vaccine hesitancy and resistance in Russia. Vaccine. 2022. PMID: 36050249. doi:10.1016/j.vaccine.2022.08.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。